image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.21
-8.81 %
$ 1.61 B
Market Cap
81.4
P/E
BALANCE SHEET
997 M ASSETS
1.14%
375 M LIABILITIES
-7.36%
622 M EQUITY
7.07%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Dynavax Technologies Corporation
image
Current Assets 859 M
Cash & Short-Term Investments 742 M
Receivables 44.5 M
Other Current Assets 72.3 M
Non-Current Assets 138 M
Long-Term Investments 0
PP&E 61.6 M
Other Non-Current Assets 76.4 M
Current Liabilities 62.2 M
Accounts Payable 5.24 M
Short-Term Debt 4.5 M
Other Current Liabilities 52.5 M
Non-Current Liabilities 313 M
Long-Term Debt 252 M
Other Non-Current Liabilities 60.4 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
ASSETS
Cash & Cash Equivalents 150.3 202.0 436.2 32.1 39.9 49.3 26.6 24.3 44.8 49.5 23.1 7.6 31.9 22.5 36.7 28.1 14.3 14.2 8.7 16.6 23.5 5.2 0 0
Short Term Investments 592.0 422.4 109.8 133.0 111.2 96.2 165.3 57.1 151.3 73.1 166.3 117.5 82.0 49.7 0 40.4 42.3 58.7 66.4 49.3 5.6 24.2 0 0
Receivables 44.5 147.5 131.8 22.7 8.9 3.7 0.9 1.3 1.4 0.7 1.6 1.0 9.5 1.0 0.9 6.4 7.2 2.2 0.7 3.1 0.2 0 0 0
Inventory 53.3 59.4 61.3 63.7 41.3 19.0 0.3 (8.2) (3.8) (4.8) 0 (3.1) 0 0 0 0 6.5 0.3 0 0 0 0 0 0
Other Current Assets 19.0 85.6 233.4 38.6 7.4 12.2 5.0 13.7 4.9 8.1 2.8 4.1 2.3 2.7 1.2 1.7 6.5 14.4 1.7 1.8 1.4 0.7 0 0
Total Current Assets 859.1 683.8 607.3 228.7 192.4 164.6 191.9 81.4 196.1 122.7 192.4 125.1 124.6 74.5 38.9 76.5 101.9 89.7 77.5 70.8 30.7 30.1 0 0
PP&E 61.6 63.3 61.0 57.1 32.0 17.1 16.6 17.2 13.8 7.9 8.7 8.0 6.2 6.4 8.0 9.5 7.3 5.2 2.2 2.5 0.8 1.3 0 0
Intangible Assets 0 0 0 0 2.5 11.7 1.3 0 0 0 0 0 0 0.3 1.3 2.3 3.2 4.4 0 0 0 0 0 0
Goodwill 2.1 2.0 2.1 2.3 2.1 2.1 2.2 2.0 2.0 2.3 2.6 2.5 2.3 2.3 2.3 2.3 2.3 2.3 0 0 0 0 0 0
Long Term Investments 0 0.2 0.2 0.2 0.2 0.6 0.6 0.6 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 74.3 236.7 368.9 65.1 50.1 15.4 8.1 9.1 4.7 5.4 1.0 4.2 1.0 0.7 0 0 5.6 1.3 0.4 0.4 18 K 51 K 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1 29.6
Total Assets 997.1 985.9 1 039.2 353.3 279.1 210.9 218.8 109.7 216.6 138.3 204.6 139.8 134.1 84.2 50.5 90.6 120.4 102.9 80.1 73.6 31.6 31.5 15.1 29.6
LIABILITIES
Accounts Payable 5.2 3.2 2.6 3.3 9.3 5.3 4.5 3.8 3.4 1.2 1.9 2.2 2.0 2.3 1.7 0.9 4.4 2.2 1.0 1.4 1.4 1.4 0 0
Short Term Debt 4.5 3.6 2.6 3.2 3.0 0 0 0 0 0 0 0 12.8 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 52.5 143.2 201.4 32.6 40.7 32.8 14.1 16.2 22.7 13.3 8.2 10.1 8.2 10.9 10.1 6.8 12.1 10.7 3.8 4.4 3.0 2.1 0 0
Total Current Liabilities 62.2 150.1 556.4 77.4 53.0 38.0 18.6 20.0 28.8 20.3 16.2 19.0 27.2 14.7 14.5 40.9 19.9 13.7 5.5 6.8 5.1 4.2 0 0
Long Term Debt 252.4 254.4 254.8 214.6 216.4 100.9 0 0 0 9.6 0 0 0 11.8 9.3 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 (11.8) 0 0 0 0 0 0 0 0 0 0
Other Liabilities 60.4 0.4 5.7 2.6 1.3 8.9 0.6 20.5 26.9 1.1 1.0 0.6 0.6 0 3.2 15.1 20.6 0.1 0.2 0.3 83.6 83.6 0 0
Total Liabilities 375.0 404.8 816.9 294.6 270.8 147.8 19.2 20.5 29.6 37.8 18.3 24.9 34.2 32.1 44.1 74.5 81.3 23.8 5.7 13.8 88.8 87.8 49.5 47.6
EQUITY
Common Stock 0.1 0.1 0.1 0.1 84 K 63 K 62 K 39 K 38 K 26 K 0.3 0.2 0.2 0.1 54 K 40 K 40 K 40 K 30 K 25 K 2 K 2 K 0 0
Retained Earnings (930.6) (924.2) (1 217.4) (1 294.1) (1 218.8) (1 066.2) (907.3) (812.2) (699.7) (592.9) (502.2) (435.5) (365.5) (316.9) (259.6) (248.7) (227.9) (167.9) (115.9) (95.3) (79.4) (62.0) (44.0) (25.6)
Other Accumulative Comprehensive Income/Loss (2.1) (5.4) (2.3) 0.3 (2.4) (2.0) (0.9) (3.6) (2.9) (1.7) (0.1) (0.6) (1.0) (0.7) (0.2) (0.4) 0.4 0.2 (2.6) (3.9) (5.3) (2.8) 0 0
Total Equity 622.1 581.0 222.4 58.7 8.3 63.1 199.5 89.2 187.1 100.5 186.3 114.8 99.9 52.1 6.4 16.2 39.1 79.1 74.4 59.9 (57.2) (56.4) (34.4) (18.0)
Total Liabilities and Equity 997.1 985.9 1 039.2 353.3 279.1 210.9 218.8 109.7 216.6 138.3 204.6 139.8 134.1 84.2 50.5 90.6 120.4 102.9 80.1 73.6 31.6 31.5 15.1 29.6
SHARES OUTSTANDING
Common Shares Outstanding 128.7 126.4 116.3 100.8 72.0 62.4 52.6 38.5 32.9 26.3 19.6 17.0 12.5 8.2 4.0 4.0 4.0 3.2 2.6 2.1 0.2 0.2 0.1 0.1